Trial Profile
A Randomised, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study to Assess the Efficacy and Safety of Esomeprazole or Omeprazole for 5 Days in Subjects With Acute Non-Variceal Upper Gastrointestinal Bleeding.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2013
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Omeprazole (Primary)
- Indications Gastrointestinal haemorrhage
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 25 Oct 2009 New trial record